I型干扰素信号在癌症中的情境依赖性影响
Ainhoa Ruiz-Iglesias1, Emma Guilbaud2, Lorenzo Galluzzi3
1Department of Immunology and Oncology, Centro Nacional Biotecnología (CNB-CSIC), Madrid, Spain.
Molecular cancer
|October 31, 2025
概括
一种类型的干扰素 (IFN) 信号可以对抗或促进癌症. 强大的IFN反应有助于癌症免疫监测,而弱的反应则促进瘤的进展和免疫抑制.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- I型干扰素 (IFN) 对于抗病毒反应至关重要.
- 在癌症的发展和治疗反应中,I型IFN信号越来越被认可.
- 它在癌症中的作用是复杂的,并且取决于背景.
研究的目的:
- 批判性地讨论I型IFN信号在癌症中的双重作用.
- 探索影响I型IFN对瘤进展和治疗影响的因素.
- 要突出类型I的IFN在瘤学中的上下文依赖性.
主要方法:
- 文献审查和现有研究的批判性讨论.
- 对瘤内在和外在因素的分析.
- 专注于I型IFN对癌细胞和瘤微环境的影响.
主要成果:
- 强大的,急性I型IFN反应通过细胞死亡和免疫细胞激活 (CTLs,NK细胞,DCs,TAMs) 来促进癌症免疫监测.
- 较弱,不溶解的I型IFN反应通过促进癌症干和创造免疫抑制瘤微环境来增强瘤的进展.
- 第一种类型的IFN信号影响恶性细胞的增殖,细胞亡,干细胞,转移和治疗耐药性.
结论:
- I型IFN对癌症的影响高度取决于背景.
- 观察到支持和反瘤原生效应,受反应动态和瘤微环境因素的影响.
- 了解这些因素是利用I型IFN进行有效的癌症免疫治疗的关键.
相关概念视频
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Intracellular Signaling Affects Focal Adhesions
3.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
3.5K
Mechanisms of Retrovirus-induced Cancers
6.8K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.8K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
The JAK-STAT Signaling Pathway
11.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.9K


